Item
1. Interim Financial Statements.
MALLARD
ACQUISITION CORP.
CONDENSED
BALANCE SHEETS
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
|
|
(Unaudited)
|
|
|
(Audited)
|
|
ASSETS
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
Cash
|
|
$
|
447,734
|
|
|
$
|
782,937
|
|
Prepaid expenses
|
|
|
313,161
|
|
|
|
292,552
|
|
Total Current Assets
|
|
|
760,895
|
|
|
|
1,075,489
|
|
|
|
|
|
|
|
|
|
|
Marketable securities held in Trust Account
|
|
|
111,104,658
|
|
|
|
111,101,918
|
|
TOTAL ASSETS
|
|
$
|
111,865,553
|
|
|
$
|
112,177,407
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
Current Liabilities - Accrued expenses
|
|
|
98,780
|
|
|
|
106,241
|
|
Warrant liability
|
|
|
13,320,000
|
|
|
|
15,750,000
|
|
Deferred underwriting fee payable
|
|
|
3,850,000
|
|
|
|
3,850,000
|
|
Total Liabilities
|
|
|
17,268,780
|
|
|
|
19,706,241
|
|
|
|
|
|
|
|
|
|
|
Commitments
|
|
|
|
|
|
|
|
|
Class A common stock subject to possible redemption 8,870,814 and 8,660,511 shares at redemption value at March 31, 2021 and December 31, 2020, respectively
|
|
|
89,596,768
|
|
|
|
87,471,161
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity
|
|
|
|
|
|
|
|
|
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
|
|
|
—
|
|
|
|
—
|
|
Common stock, $0.0001 par value; 100,000,000 shares authorized; 4,879,186 and 5,089,489 issued and outstanding (excluding 8,870,814 and 8,660,511 shares subject to possible redemption) at March 31, 2021 and December 31, 2020, respectively
|
|
|
488
|
|
|
|
509
|
|
Additional paid-in capital
|
|
|
1,588,690
|
|
|
|
3,714,276
|
|
Retained earnings
|
|
|
3,410,827
|
|
|
|
1,285,220
|
|
Total Stockholders’ Equity
|
|
|
5,000,005
|
|
|
|
5,000,005
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
$
|
111,865,553
|
|
|
$
|
112,177,407
|
|
The
accompanying notes are an integral part of the unaudited condensed financial statements.
MALLARD
ACQUISITION CORP.
CONDENSED
STATEMENTS OF OPERATIONS
(UNAUDITED)
|
|
Three Months Ended
March 31,
|
|
|
For the
Period from
February 26,
2020 (Inception)
Through
March 31,
|
|
|
|
2021
|
|
|
2020
|
|
Formation and operating costs
|
|
$
|
307,133
|
|
|
$
|
1,000
|
|
Loss from operations
|
|
|
(307,133
|
)
|
|
|
(1,000
|
)
|
|
|
|
|
|
|
|
|
|
Other income:
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liability
|
|
|
2,430,000
|
|
|
|
—
|
|
Interest earned on marketable securities held in Trust Account
|
|
|
2,740
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
2,125,607
|
|
|
$
|
(1,000
|
)
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, common stock subject to redemption
|
|
|
8,870,814
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income per share, common stock subject to redemption
|
|
$
|
0.00
|
|
|
$
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Common stock(1)
|
|
|
22,967,139
|
|
|
|
2,750,000
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income per share, Common stock
|
|
$
|
0.09
|
|
|
$
|
0.00
|
|
(1)
|
For
the period from February 26, 2020 (inception) through March 31, 2020, excluded an aggregate of up to 412,500 shares of common stock subject
to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part by the underwriters
(see Note 5). In December 2020, the underwriters’ election to exercise their over-allotment option expired unexercised, resulting
in the forfeiture of 412,500 shares. Accordingly, for the period from February 26, 2020 (inception) through March 31, 2020, 2,750,000
Founder Shares remained issued and outstanding.
|
The
accompanying notes are an integral part of the unaudited condensed financial statements.
MALLARD
ACQUISITION CORP.
CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)
THREE
MONTHS ENDED MARCH 31, 2021
|
|
Common Stock
|
|
|
Additional
Paid
|
|
|
Retained
|
|
|
Total
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
in Capital
|
|
|
Earnings
|
|
|
Equity
|
|
Balance – January 1, 2021
|
|
|
5,089,489
|
|
|
$
|
509
|
|
|
$
|
3,714,276
|
|
|
$
|
1,285,220
|
|
|
$
|
5,000,005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in value of common stock subject to redemption
|
|
|
(210,303
|
)
|
|
|
(21
|
)
|
|
|
(2,125,586
|
)
|
|
|
—
|
|
|
|
(2,125,607
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,125,607
|
|
|
|
2,125,607
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance – March 31, 2021
|
|
|
4,879,186
|
|
|
$
|
488
|
|
|
$
|
1,588,690
|
|
|
$
|
3,410,827
|
|
|
$
|
5,000,005
|
|
FOR
THE PERIOD FROM FEBRUARY 26, 2020 (INCEPTION) TO MARCH 31, 2020
|
|
Common Stock
|
|
|
Additional
Paid
|
|
|
Accumulated
|
|
|
Total
Stockholders’
|
|
|
|
Shares
|
|
|
in Capital
|
|
|
Earnings
|
|
|
Deficit
|
|
|
Equity
|
|
Balance – February 26, 2020 (inception)
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock to Sponsor(1)
|
|
|
3,162,500
|
|
|
|
316
|
|
|
|
24,684
|
|
|
|
—
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,000
|
)
|
|
|
(1,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance – March 31, 2020
|
|
|
3,162,500
|
|
|
$
|
316
|
|
|
$
|
24,684
|
|
|
$
|
(1,000
|
)
|
|
$
|
24,000
|
|
(1)
|
For
the period from February 26, 2020 (inception) through March 31, 2020, included an aggregate of up to 412,500 shares of common
stock subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or
in part by the underwriters (see Note 5). In December 2020, the underwriters’ election to exercise their over-allotment
option expired unexercised, resulting in the forfeiture of 412,500 shares.
|
The
accompanying notes are an integral part of the unaudited condensed financial statements.
MALLARD
ACQUISITION CORP.
CONDENSED
STATEMENTS OF CASH FLOWS
(UNAUDITED)
|
|
Three Months Ended
March 31,
|
|
|
For the
Period from
February 26,
2020 (Inception)
Through
March 31,
|
|
|
|
2021
|
|
|
2020
|
|
Cash Flows from Operating Activities:
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2,125,607
|
|
|
$
|
(1,000
|
)
|
Adjustments to reconcile net income (loss) to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liability
|
|
|
(2,430,000
|
)
|
|
|
—
|
|
Interest earned on marketable securities held in Trust Account
|
|
|
(2,740
|
)
|
|
|
—
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
|
(20,609
|
)
|
|
|
—
|
|
Accrued expenses
|
|
|
(7,461
|
)
|
|
|
1,000
|
|
Net cash used in operating activities
|
|
|
(335,203
|
)
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities:
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock to Sponsor
|
|
|
—
|
|
|
|
25,000
|
|
Proceeds from promissory note – related party
|
|
|
—
|
|
|
|
87,500
|
|
Payment of offering costs
|
|
|
—
|
|
|
|
(87,500
|
)
|
Net cash provided by financing activities
|
|
|
—
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
Net Change in Cash
|
|
|
(335,203
|
)
|
|
|
25,000
|
|
Cash – Beginning of period
|
|
|
782,937
|
|
|
|
—
|
|
Cash – End of period
|
|
$
|
447,734
|
|
|
$
|
25,000
|
|
|
|
|
|
|
|
|
|
|
Non-Cash investing and financing activities:
|
|
|
|
|
|
|
|
|
Offering costs included in accrued offering costs
|
|
$
|
—
|
|
|
$
|
5,000
|
|
Change in value of common stock subject to possible redemption
|
|
$
|
2,125,607
|
|
|
$
|
—
|
|
The
accompanying notes are an integral part of the unaudited condensed financial statements.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Mallard
Acquisition Corp. (the “Company”) was incorporated in Delaware on February 26, 2020. The Company was formed for the
purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses (the “Business Combination”).
Although
the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company
intends to focus its search on companies in the value-added distribution, industrial specialty services, and differentiated manufacturing
sectors. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated
with early stage and emerging growth companies.
As
of March 31, 2021, the Company had not commenced any operations. All activity for the period from February 26, 2020 (inception)
through March 31, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”),
which is described below. The Company will not generate any operating revenues until after the completion of its initial Business
Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.
The
registration statement for the Company’s Initial Public Offering was declared effective on October 27, 2020. On October
29, 2020, the Company consummated the Initial Public Offering of 11,000,000 units (the “Units” and, with respect to
the shares of common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross
proceeds of $110,000,000, which is described in Note 4.
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 10,000,000 warrants (the “Private Placement
Warrants”) at a price of $0.50 per Private Placement Warrant in a private placement to Mallard Founders Holdings LLC, a
Delaware limited liability company (the “Sponsor”), generating gross proceeds of $5,000,000, which is described in
Note 5.
Transaction
costs amounted to $6,569,054 consisting of $2,200,000 of underwriting fees, $3,850,000 of deferred underwriting fees and $519,054
of other offering costs.
Following
the closing of the Initial Public Offering on October 29, 2020, an amount of $111,100,000 ($10.10 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the “Trust Account”) located in the United States and invested only in U.S. government securities, within the meaning
set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with
a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by
the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier
of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described
below.
The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public
Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied
generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business
Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have
an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions
and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination.
The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required
to register as an investment company under the Investment Company Act.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
The
Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity
to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with
a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether
the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely
in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount
then in the Trust Account (initially $10.10 per Public Share, plus any pro rata interest earned on the funds held in the Trust
Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public
Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay
to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination
with respect to the Company’s warrants.
The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior
to or upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted
are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to
hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation (the
“Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities
and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination.
If, however, stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval
for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the
proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business
Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased
during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder
may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.
If
the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer
rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or
any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with
respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection
with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) that
would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does
not complete a Business Combination within 18 months from the closing of the Initial Public Offering or (ii) with respect to any
other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides
the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
The
Company will have until April 29, 2022 to complete a Business Combination (the “Combination Period”). If the Company
is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for
the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the
Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less
up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption
will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating
distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate,
subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements
of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants,
which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
The
Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business
Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares after
the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company
fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to
their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business
Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust
Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible
that the per share value of the assets remaining available for distribution will be less than the amount initially funded in the
Trust Account ($10.10 per share).
In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent
any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10
per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation
of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn
to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights
to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the
Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities
Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will
not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility
that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service
providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities
with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind
in or to monies held in the Trust Account.
Liquidity
and Going Concern
As
of March 31, 2021, the Company had $447,734 in its operating bank accounts, $111,104,658 in securities held in the Trust Account
to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital
of $712,115.
Until
the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying
and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel
expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.
The
Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers,
directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company
funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s
working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise
additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily
be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company
cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions
raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date of these
financial statements if a Business Combination is not consummated. These financial statements do not include any adjustments relating
to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be
unable to continue as a going concern.
Risks
and Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company,
the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions
to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial
statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for
interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation
of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed
financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation
of the financial position, operating results and cash flows for the periods presented.
The
accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on
Form 10-K for the period ended December 31, 2020, as filed with the SEC on April 22, 2021. The interim results for the three months
ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for
any future periods.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to,
not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of
the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy
statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The
Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use
of Estimates
The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020.
Marketable
Securities Held in Trust Account
At
March 31, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds
which are invested primarily in U.S. Treasury securities.
Warrant
Liability
The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s
specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”)
and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet
all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s
own shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside
of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional
judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants
are outstanding.
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded
as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the
criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance,
and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain
or loss on the statements of operations. The fair value of the warrants was estimated using both a probability adjusted Black-Scholes
option pricing model and a Monte Carlo simulation approach (see Note 9).
Class
A Common Stock Subject to Possible Redemption
The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption
is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common
stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are
considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at
March 31, 2021 and December 31, 2020, common stock subject to possible redemption is presented at redemption value as temporary
equity, outside of the stockholders’ equity section of the Company’s balance sheets.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Offering
Costs
Offering
costs consist of legal, accounting and other costs incurred through the balance sheet date that are directly related to the Initial
Public Offering. Offering costs amounting to $6,569,054 were charged to stockholders’ equity upon the completion of the
Initial Public Offering (see Note 1).
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.”
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between
the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets
and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary,
to reduce deferred tax assets to the amount expected to be realized.
ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for
interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company is subject to
income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate
of 21% for the three months ended March 31, 2021 and for the period from February 26, 2020 (inception) through March 31, 2020,
due to the valuation allowance recorded on the Company’s net operating losses.
On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates
and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including
among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”)
for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement
property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules
including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable
years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum
tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did
not have an impact on the financial statements.
Net
income (Loss) per Common Share
Net
income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during
the period, excluding shares of common stock forfeited. The Company has not considered the effect of the warrants sold in the
Initial Public Offering and private placement to purchase an aggregate of 10,500,000 shares in the calculation of diluted loss
per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants
would be anti-dilutive.
The
Company’s statement of operations includes a presentation of loss per share for common shares subject to possible redemption
in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for Common stock
subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held
by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to
possible redemption outstanding since original issuance.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Net
income per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income
or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable common stock outstanding for the period.
Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income or loss on marketable securities based on non-redeemable shares’
proportionate interest.
The
following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share
amounts):
|
|
Three
Months Ended
March 31,
2021
|
|
|
For the Period from
February 26,
2020 (Inception)
Through
March 31,
2020
|
|
Common stock subject to possible redemption
|
|
|
|
|
|
|
|
|
Numerator: Earnings allocable to common stock subject to possible redemption
|
|
|
|
|
|
|
|
|
Interest earned on marketable securities held in Trust Account
|
|
$
|
2,740
|
|
|
$
|
—
|
|
Unrealized gain (loss) on marketable securities held in Trust Account
|
|
|
|
|
|
|
—
|
|
Less: interest available to be withdrawn for payment of taxes
|
|
|
(2,740
|
)
|
|
|
—
|
|
Net income allocable to Common stock subject to possible redemption
|
|
$
|
—
|
|
|
$
|
—
|
|
Denominator: Weighted Average common stock subject to possible redemption
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
|
|
|
8,870,814
|
|
|
|
—
|
|
Basic and diluted net income per share, common stock subject to possible redemption
|
|
$
|
0.00
|
|
|
$
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Non-Redeemable Common Stock
|
|
|
|
|
|
|
|
|
Numerator: Net Income minus Net Earnings
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2,125,607
|
|
|
$
|
(1,000
|
)
|
Less: Net income allocable to common stock subject to possible redemption
|
|
|
—
|
|
|
|
—
|
|
Non-Redeemable Net Earnings (Loss)
|
|
$
|
2,125,607
|
|
|
$
|
(1,000
|
)
|
Denominator: Weighted Average Non-redeemable Common stock
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Non-redeemable Common stock
|
|
|
22,967,139
|
|
|
|
2,750,000
|
|
Basic and diluted net earnings (loss) per share, Non-redeemable Common stock
|
|
$
|
0.09
|
|
|
$
|
(0.00
|
)
|
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced
losses on this account and management believes the Company is not exposed to significant risks on such account.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair
Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily
due to their short-term nature.
Recent
Accounting Standards
Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company’s condensed financial statements.
NOTE
3. INITIAL PUBLIC OFFERING
Pursuant
to the Initial Public Offering, the Company sold 11,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share
of common stock and one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase
one-half of one share of common stock at a price of $11.50 per whole share, subject to adjustment (see Note 8).
NOTE
4. PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 10,000,000 Private Placement Warrants at
a price of $0.50 per Private Placement Warrant, for an aggregate purchase price of $5,000,000. The Sponsor agreed to purchase
up to an additional 900,000 Private Placement Warrants at a price of $0.50 per Private Placement Warrant, or an aggregate of $450,000,
to the extent the underwriters exercise their over-allotment option in full or in part. However, the over-allotment option was
not exercised and expired in December 2020. Each Private Placement Warrant is exercisable to purchase one-half of one share of
common stock at a price of $11.50 per whole share. A portion of the proceeds from the Private Placement Warrants were added to
the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination
within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption
of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.
There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Placement Warrants.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
NOTE
5. RELATED PARTY TRANSACTIONS
Founder
Shares
On
February 26, 2020, the Sponsor purchased 2,875,000 shares (the “Founder Shares”) of the Company’s common stock
for an aggregate consideration of $25,000. On October 20, 2020, the Company effectuated a stock dividend of 0.1 share for each
share of its outstanding common stock resulting in an aggregate of 3,162,500 Founder Shares outstanding. The Founder Shares included
an aggregate of up 412,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not
exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding
shares after the Initial Public Offering (assuming the Sponsor does not purchase any Public Shares in the Initial Public Offering).
In December 2020, the underwriters’ election to exercise their over-allotment option expired unexercised, resulting in the
forfeiture of 412,500 shares. Accordingly, 2,750,000 Founder Shares remain issued and outstanding.
The
Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell (A) with respect to 50% of the Founder Shares,
for a period ending on the earlier to occur of the six-month anniversary of the completion of a Business Combination or the date
on which the closing price of the common stock exceeds $12.50 for any 20 trading days within a 30-day trading period following
the closing of a Business Combination; (B) with respect to the remaining 50% of the Founder Shares, for a period ending on the
six-month anniversary of the closing of a Business Combination or (C) in each case, subsequent to a Business Combination, the
date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in
all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Promissory
Note — Related Party
On
February 26, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial
Public Offering (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of
December 31, 2020 or the consummation of the Initial Public Offering. The Company repaid the entire outstanding balance of $285,392
under the Promissory Note on November 2, 2020.
Advance
from Sponsor
As
of October 29, 2020, the Sponsor advanced $450,000 to the Company in anticipation of the amount to be paid for the purchase of
additional Private Placement Warrants in the event the underwriters’ exercised their over-allotment option. The advance
was due on demand should the over-allotment option not be exercised by the underwriters. The Company repaid the $450,000 advance
from the Sponsor on November 4, 2020.
Related
Party Loans
In
addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the
Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may
be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the
Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would
be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company
may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust
Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if
any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000
of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $0.50 per
warrant. The warrants would be identical to the Private Placement Warrants.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
NOTE
6. COMMITMENTS
Registration
Rights
Pursuant
to a registration rights agreement entered into on October 27, 2020, the holders of the Founder Shares, Private Placement Warrants
and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise
of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to
registration rights requiring the Company to register such securities for resale. The holders of the majority of these securities
will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition,
the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant
to Rule 415 under the Securities Act. The registration rights agreement will not contain liquidating damages or other cash
settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses
incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The
underwriters are entitled to a deferred fee of $0.35 per Unit, or $3,850,000 in the aggregate.
Right
of First Refusal
Subject
to certain conditions, the Company granted Chardan Capital Markets, LLC, for a period of 15 months after the date of the consummation
of a Business Combination, a right of first refusal to act as lead underwriters or minimally as a co-manager, with at least 30%
of the economics; or, in the case of a three-handed deal 20% of the economics, for any and all future public and private equity
and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration
of more than three years from the effective date of the Initial Public Offering.
Anchor
Investment
In
connection with the closing of the Initial Public Offering, certain qualified institutional buyers or institutional accredited
investors not affiliated with any member of the Company’s management (the “anchor investors”) purchased an aggregate
of 10,370,000 Units. Separately, each of the anchor investors entered into a separate agreement with the Sponsor pursuant
to which such investors purchased membership interests in the Sponsor representing indirect beneficial interests in up to 60,500
Founder Shares and 224,490 Private Placement Warrants upon closing of the Initial Public Offering.
Neither
the membership interests in the Sponsor nor the Founder Shares or Private Placement Warrants to be indirectly owned by such investors
will be subject to forfeiture without their consent.
The
price paid by the anchor investors for the preceding Founder Share and Private Placement Warrant membership interests is approximately
the same, proportionally, as that paid by the other members of the Sponsor, collectively, for the rest of such membership interests.
There
can be no assurance as to the number of Units the anchor investors will retain, if any, prior to or upon the consummation of a
Business Combination. In the event that the anchor investors purchase such Units and vote them in favor of a Business Combination,
a smaller portion of affirmative votes from other public stockholders would be required to approve a Business Combination.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
NOTE
7. STOCKHOLDERS’ EQUITY
Preferred
Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share
with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s
board of directors. At March 31, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.
Common
Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001
per share. Holders of common stock are entitled to one vote for each share. At March 31, 2021 and December 31, 2020, there were
4,879,186 and 5,089,489 shares of common stock issued or outstanding, excluding 8,870,814 and 8,660,511 shares of common stock
subject to possible redemption, respectively.
NOTE
8. WARRANT LIABILITY
The
Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business
Combination or earlier upon redemption or liquidation.
The
Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common
stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any
shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The
Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination,
the Company will use its reasonable best efforts to file, and within 60 business days following a Business Combination to have
declared effective, a registration statement for the registration, under the Securities Act, of the shares of common stock issuable
upon exercise of the warrants. The Company will use its reasonable best efforts to maintain the effectiveness of such registration
statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of
the warrant agreement. Notwithstanding the above, if the common stock is at the time of any exercise of a warrant not listed on
a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1)
of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so
on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects,
the Company will not be required to file or maintain in effect a registration statement, but will be required to use its best
efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Once
the warrants become exercisable, the Company may redeem the Public Warrants:
|
●
|
in whole
and not in part;
|
|
|
|
|
●
|
at a price of $0.01
per warrant;
|
|
|
|
|
●
|
if, and only if,
the reported last sale price of the Company’s common stock equals or exceeds $16.50 per share for any 20 trading days
within a 30-trading day period ending three business days before the Company sends the notice of redemption to each warrant
holder.
|
If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to
register or qualify the underlying securities for sale under all applicable state securities laws.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise
the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and
number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in
the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below,
the warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event
will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within
the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any
of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside
of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In
addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes
in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share
of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of
directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares
held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the
aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and
(z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on
the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”)
is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of
the greater of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted
(to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.
The
Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except
that the Private Placement Warrants and the common stock issuable upon the exercise of the Private Placement Warrants will not
be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited
exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long
as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone
other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company
and exercisable by such holders on the same basis as the Public Warrants.
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
NOTE
9. FAIR VALUE MEASUREMENTS
The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value
at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company
would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an
orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets
and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and
to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).
The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable
inputs used in order to value the assets and liabilities:
|
Level 1:
|
Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing
basis.
|
|
|
|
|
Level 2:
|
Observable inputs
other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.
|
|
|
|
|
Level 3:
|
Unobservable inputs
based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
|
At
March 31, 2021 and December 31, 2020, investments held in the Trust Account were comprised of $111,104,658 and $111,101,918 in
money market funds which are invested primarily in U.S. Treasury Securities, respectively. Through March 31, 2021, the Company
did not withdraw any interest income from the Trust Account.
At
March 31, 2021 and December 31, 2020, there were 11,000,000 Public Warrants and 10,000,000 Private Placement Warrants outstanding.
The
following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring
basis at March 31, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized
to determine such fair value:
Description
|
|
March 31,
2021
|
|
|
Quoted Prices
in Active
Markets
(Level 1)
|
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
|
Significant
Other
Unobservable
Inputs
(Level 3)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments held in Trust Account
|
|
$
|
111,104,658
|
|
|
$
|
111,104,658
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant Liability – Public Warrants
|
|
$
|
4,950,000
|
|
|
$
|
4,950,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Warrant Liability – Private Placement Warrants
|
|
$
|
8,370,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,370,000
|
|
MALLARD ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)
Description
|
|
December 31,
2020
|
|
|
Quoted
Prices
in
Active
Markets
(Level
1)
|
|
|
Significant
Other
Observable
Inputs
(Level
2)
|
|
|
Significant
Other
Unobservable
Inputs
(Level
3)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments held in Trust Account
|
|
$
|
111,101,918
|
|
|
$
|
111,101,918
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant Liability – Public Warrants
|
|
$
|
8,800,000
|
|
|
$
|
8,800,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Warrant Liability – Private Placement Warrants
|
|
$
|
6,950,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,950,000
|
|
The
fair value of the Private Placement Warrants was estimated using a probability adjusted Black-Scholes option pricing model. The
assumptions under the model include the underlying stock price, strike price, risk-free interest rate, estimated volatility, the
expected term, and probability of an expected acquisition. Expected stock price volatility is based on the actual historical volatility
of a group of comparable publicly traded companies observed over a historical period equal to the expected remaining life of the
Private Placement Warrants. The fair value of the underlying shares is the published closing market price on the Nasdaq Capital
Market as of each reporting date, as adjusted for significant results, as necessary. The risk-free interest rate is based on the
U.S. Treasury yield curve in effect on the date of valuation equal to the remaining expected life of the Private Placement Warrants.
The dividend yield percentage is zero because the Company does not currently pay dividends, nor does it intend to do so during
the expected term of the Private Placement Warrants. The fair value of the Public Warrants was determined using the close price
as of the reporting date.
The
fair value of the Private Placement Warrants was estimated at December 31, 2020 using the Black-Scholes model and the following
assumptions:
|
|
March 31,
2021
|
|
|
December 31,
2020
|
|
Estimated dividend yield
|
|
|
—
|
|
|
|
--
|
|
Expected volatility
|
|
|
18
|
%
|
|
|
25
|
%
|
Risk-free interest rate
|
|
|
0.76
|
%
|
|
|
0.36
|
%
|
Expected term (years)
|
|
|
4.92
|
|
|
|
5.00
|
|
The
following table presents the changes in the fair value of warrant liabilities:
|
|
Private
Placement
|
|
|
Public
|
|
|
Warrant
Liabilities
|
|
Fair value as of January 1, 2021
|
|
$
|
6,950,000
|
|
|
$
|
8,800,000
|
|
|
$
|
15,750,000
|
|
Change in valuation inputs or other assumptions
|
|
|
1,420,000
|
|
|
|
(3,850,000
|
)
|
|
|
(2,430,000
|
)
|
Fair value as of March 31, 2021
|
|
$
|
8,370,000
|
|
|
$
|
4,950,000
|
|
|
$
|
13,320,000
|
|
There
were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
NOTE
10. SUBSEQUENT EVENTS
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed
financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the condensed financial statements.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References
in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to
Mallard Acquisition Corp. References to our “management” or our “management team” refer to our officers
and directors, and references to the “Sponsor” refer to Mallard Founders Holdings LLC. The following discussion and
analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion
and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special
Note Regarding Forward-Looking Statements
This
Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual
results to differ materially from those expected and projected. All statements, other than statements of historical fact included
in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the
Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking
statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,”
“seek” and variations and similar words and expressions are intended to identify such forward-looking statements.
Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially
from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed
Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ
materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s
Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s
securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required
by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements
whether as a result of new information, future events or otherwise.
Overview
We
are a blank check company formed under the laws of the State of Delaware on February 26, 2020, for the purpose of effecting a
merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses
(the “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of the
Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock
and debt.
We
expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to
complete a Business Combination will be successful.
Results
of Operations
We
have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through
March 31, 2021 were organizational activities and those necessary to prepare for the Initial Public Offering, described below.
We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect
to generate non-operating income in the form of interest income on investments held after the Initial Public Offering. We expect
that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing
compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.
For
the three months ended March 31, 2021, we had a net income of $2,125,607, which consists of the change in fair value of warrant
liability of $2,430,000, and interest earned on marketable securities held in our Trust Account of $2,740, offset by formation
and operating costs of $307,133.
For
the period from February 26, 2020 (inception) through March 31, 2020, we had net loss $1,000, which consisted of formation and
operating costs.
Liquidity
and Capital Resources
On
October 29, 2020, we completed the Initial Public Offering of 11,000,000 Units at $10.00 per Unit, generating gross proceeds of
$110,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,000,000 Private
Placement Warrants at a price of $0.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds
of $5,000,000.
For
the three months ended March 31, 2021, cash used in operating activities was $335,203. Net income of $2,125,607 was affected by
the change in fair value of warrant liability of $2,430,000 and interest earned on marketable securities held in the Trust Account
of $2,740. Changes in operating assets and liabilities used $28,070 of cash for operating activities.
For
the period from February 26, 2020 (inception) through March 31, 2020, net cash used in operating activities was $0. Net loss of
$1,000. Changes in operating assets and liabilities provided $1,000 of cash for operating activities.
As
of March 31, 2021, we had marketable securities held in the Trust Account of $111,104,658 (including approximately $2,740 of interest
income) consisting of securities held in a money market fund that invests in U.S. Treasury securities with a maturity of 185 days
or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through March 31, 2021, we did not
withdraw any interest earned on the Trust Account to pay our taxes. We intend to use substantially all of the funds held in the
Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be net of taxes payable
and excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust
Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete
a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations
of the target business or businesses, make other acquisitions and pursue our growth strategies.
As
of March 31, 2021, we had cash of $447,734. We intend to use the funds held outside the Trust Account primarily to identify and
evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants
or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In
order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor
or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be
required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released
to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust
Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000
of such loans may be convertible into warrants of the post Business Combination entity, at a price of $0.50 per warrant, at the
option of the lender. The warrants would be identical to the Private Placement Warrants.
We
monitor the adequacy of our working capital in order to meet the expenditures required for operating our business prior to our
initial Business Combination. However, if our estimates of the costs of identifying a target business, undertaking in-depth due
diligence and negotiating an initial Business Combination are less than the actual amount necessary to do so, we may have insufficient
funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing
either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares
upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with
such Business Combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds
available to us, we will be forced to cease operations and liquidate the Trust Account.
The
Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers,
directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company
funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s
working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise
additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily
be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company
cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions
raise substantial doubt about the Company’s ability to continue as a going concern if a Business Combination is not consummated.
Off-Balance
Sheet Arrangements
We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2021. We
do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred
to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any
debt or commitments of other entities, or purchased any non-financial assets.
Contractual
obligations
We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.
The
underwriters are entitled to a deferred fee of $0.35 per Unit, or $3,850,000 in the aggregate.
Critical
Accounting Policies
The
preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted
in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical
accounting policies:
Warrant
Liability
We
account for the private and public warrants issued in connection with our Initial Public Offering in accordance with the guidance
contained in ASC 815-40-15-7D under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities.
Accordingly, we classify the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting
period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is
recognized in our statement of operations. The fair value of the warrants was estimated by using both a probability adjusted Black-Scholes
option pricing model and a Monte Carlo simulation approach.
Common
Stock Subject to Possible Redemption
We
account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption
is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock
that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified
as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control
and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders’ equity section of our condensed balance sheets.
Net
Income (Loss) Per Common Share
We
apply the two-class method in calculating earnings per share. Net income (loss) per common share, basic and diluted for Class A
common stock subject to possible redemption is calculated by dividing the interest income earned on the Trust Account, net of
applicable taxes, if any, by the weighted average number of shares of Class A common stock subject to possible redemption
outstanding for the period. Net income (loss) per common share, basic and diluted for and non-redeemable common stock is calculated
by dividing net loss less income attributable to Class A common stock subject to possible redemption, by the weighted average
number of shares of non-redeemable common stock outstanding for the period presented.
Recent
Accounting Standards
Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on our condensed financial statements.